RIL
HLVX

Rothschild Investment LLC’s HilleVax HLVX Stock Holding History

Rothschild Investment LLC’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-395
Closed -$573 – 3097
2025
Q1 		$573 Buy
395
+110
+39% +$203 ﹤0.01% 2578
2024
Q4 		$590 Buy
+285
New +$535 ﹤0.01% 2469
2024
Q3 		– Sell
-10
Closed -$145 – 2936
2024
Q2 		$145 Buy
+10
New +$137 ﹤0.01% 2585

Other funds holding HLVX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
LMC
Lightspeed Management Company Menlo Park, California $988M AUM 7.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Rothschild Investment LLC's HLVX Position: Q2 2025 in Review

Rothschild Investment LLC sold out of HilleVax (HLVX) in Q2 2025, closing a stake of 395 shares — an estimated $573 sold.

Rothschild Investment LLC first reported a position in HLVX in Q2 2024 and held it in 3 quarters. The position peaked at $590 in Q4 2024. 74 funds tracked by Wall St. Rank hold HLVX as of Q2 2025.

  • Rothschild Investment LLC reported no remaining HilleVax position as of Q2 2025 after selling out during the quarter.
  • Rothschild Investment LLC sold 395 HilleVax shares in Q2 2025, an estimated $573.
  • Rothschild Investment LLC first reported a position in HilleVax in Q2 2024 and held it in 3 quarters.
  • Rothschild Investment LLC's HilleVax position peaked at $590 in Q4 2024.
  • 74 funds tracked by Wall St. Rank held HilleVax as of Q2 2025.

Based on Rothschild Investment LLC's 13F filing for Q2 2025, filed 11 Aug 2025.